The Vascular Checkup

Heart disease remains the leading killer of men, and the tests that catch it early are cheap, boring, and decades old — which is exactly why they get skipped. This page covers the two numbers that do the real work, how to measure them properly, the add-on tests that occasionally earn their cost, and what a bad result actually obligates you to do next.

The Two Numbers That Do the Work

Strip the vascular checkup down and two measurements carry almost all the weight: blood pressure and the lipid panel. Everything else — calcium scores, ApoB, fancy wearables — is refinement on top of these two. The men's cardiovascular topic documents why the gap matters: men develop cardiovascular disease earlier than women, and the male excess shows up in the forties and fifties, not the seventies. The screening response is correspondingly simple: measure both numbers on a real schedule, measure them correctly, and act on the trend rather than the single reading. The rest of this page is the fine print on how — because in practice, most of the failure happens inside those three instructions.

Blood Pressure, Measured Properly

Blood pressure is the most-tested measurement in medicine and the most frequently botched. The ACC/AHA guideline (Whelton et al., Hypertension, 2018) defines hypertension at 130/80 mmHg — a threshold change from the older 140/90 that pulled millions of middle-aged adults into the zone where lifestyle and sometimes medication are discussed. But the number is only as good as the measurement, and the measurement has rules:

• 🪑 Sit first. Five quiet minutes, back supported, feet flat on the floor, arm at heart level, no caffeine, exercise, or nicotine in the prior 30 minutes. Skipping this inflates the reading — the classic white-coat effect is partly a no-sit effect.
• 📏 Average two readings. A single office number is a snapshot of a noisy signal; two readings, averaged, are the minimum standard for a diagnosis.
• 🏠 Bring home numbers. One elevated office reading is not hypertension. A week of twice-daily home readings decides between white-coat hypertension (high in office, normal at home) and masked hypertension (normal in office, high at home — which carries nearly the risk of sustained hypertension). The blood pressure protocol runs the full home-monitoring routine.
• 📏 Cuff size matters. An undersized cuff on a large arm can add meaningful points to the reading — if the cuff barely fits, say so and ask for a large one.

Under the 130/80 definition, 46.7% of US adults have hypertension (Tsao et al., AHA Heart Disease and Stroke Statistics, Circulation, 2024) — and roughly half of them don't have it controlled. That is the single biggest gap in men's preventive care, and it closes one home reading at a time.

Lipids: What the Standard Panel Misses

The standard lipid panel reports LDL cholesterol, HDL, and triglycerides — and for a low-risk man with a clean family history, that is genuinely enough to start. The AHA/ACC cholesterol guideline (Grundy et al., Circulation, 2019) suggests a full panel every 4–6 years for adults at low risk, which is the cadence the lipid panel topic walks through in detail. But the standard panel has a blind spot worth knowing about: LDL-C is a measure of cholesterol mass, not particle count. Two men with identical LDL can carry different numbers of atherogenic particles, and the one with more particles is at higher risk. Two add-ons close the gap, and both come from the same tube of blood:

• 🧮 Non-HDL cholesterol, free. Total cholesterol minus HDL — already on your report, no extra cost, and the guidelines treat it as a primary target in many settings.
• 🧪 ApoB, the particle count itself. One protein per atherogenic particle, so it measures what actually invades the artery wall. Many analyses find it tracks risk better than LDL-C; it is not yet the default on every lab slip, but it costs little to ask for.
• 🧫 Lp(a), once in a lifetime. A genetically set lipoprotein that predicts risk independently of everything else. You cannot meaningfully lower it with diet, but knowing it runs high changes statin decisions — the guidelines suggest a one-time measurement may be considered.

The Tests Men Skip

The pattern in routine practice is consistent: the cheap, decades-old tests happen sometimes, and the informative add-ons almost never. The chart below is the shape of the problem, not a survey — the point is the slope.

The Vascular Menu

The Calcium Score Question

A coronary artery calcium (CAC) scan is a low-dose CT that measures calcified plaque directly — and it is the most seductive add-on in the vascular menu, because the result is a single number a man can watch. In the MESA cohort, calcium score predicted coronary events strongly and independently of traditional risk factors across four ethnic groups (Detrano et al., NEJM, 2008), and adding it to standard risk models reclassified a meaningful share of intermediate-risk people into more accurate categories (Polonsky et al., JAMA, 2010). A score of zero is genuinely reassuring: event rates in the following decade are low. That is the honest upside. The honest downside: the USPSTF rates nontraditional risk markers — including CAC — insufficient for routine risk assessment (2018), because the evidence that scanning changes outcomes, rather than just numbers, is still being built. The practical rule that emerges: the scan earns its cost when the result would change a decision you are actually facing — usually a middle-aged man at intermediate estimated risk deciding whether a statin conversation is worth having. If your risk is already clearly high, treat it; if clearly low, a zero will flatter you and a high score will panic you, and neither changes what you should do.

From Numbers to Action

A vascular checkup is only worth its co-pay if it changes behavior. The evidence on what actually moves these numbers is held by the pillars that own it: the blood pressure protocol for the measurement-to-action path, the blood pressure topic for the lifestyle levers with the biggest effect sizes, the zone 2 training topic and resistance work for the aerobic and strength side, and the sleep pillar for the overnight dip that a bad night erases. Two cautions close the loop. First, statins and blood-pressure medication are clinician territory — the decision to start, adjust, or stop belongs in a real conversation, not a self-audit. Second, resist the temptation to chase the number itself: the goal is a trend inside the target range, not a personal best. A man who re-tests his lipids monthly to optimize a digit has confused the dashboard with the drive.

Related Topics